Repros Therapeutics, Inc. (RPRX)

[exwannabe]

The "dark side" of T replacement

I know we generally don't discuss this, but one has to seriously ask how much of the Androgel class drugs go out back door?

If this is signifcant (and I strongly suspect it is) then the EU approval would be almost as good as FDA.

Yes, I understand that Andoroxal dosn't raise T to supra-normal levels, but there are still many who will opt for it because of the side effect profile.

Yes, stuff like this is why the Andoroxal partner will not be big pharma. But it's also why And. has more value than the FDA process implies.